“Efficacy and Safety of Roflumilast Foam 0.3% in Patients With Seborrheic Dermatitis in a Phase 3 Trial”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s196. Accessed May 17, 2025. https://skin.dermsquared.com/skin/article/view/2037.